MedPath

GLAUKOS CORP.

GLAUKOS CORP. logo
🇺🇸United States
Ownership
Public
Established
1998-01-01
Employees
907
Market Cap
$7.4B
Website
http://www.glaukos.com

Safety and Efficacy Study for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia After Refractive Surgery

Phase 3
Withdrawn
Conditions
Corneal Ectasia
First Posted Date
2012-07-18
Last Posted Date
2021-04-26
Lead Sponsor
Glaukos Corporation
Registration Number
NCT01643252

Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus

Phase 3
Completed
Conditions
Keratoconus
Interventions
Drug: placebo solution
Device: KXL System
First Posted Date
2012-07-18
Last Posted Date
2021-04-26
Lead Sponsor
Glaukos Corporation
Target Recruit Count
230
Registration Number
NCT01643226
Locations
🇺🇸

Durrie Vision, Overland Park, Kansas, United States

🇺🇸

Columbia University Harkness Eye Institute, New York, New York, United States

🇺🇸

Cornea & Laser Eye Institute; Hersh Vision Group, Teaneck, New Jersey, United States

and more 5 locations

One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

Not Applicable
Completed
Conditions
Primary Open Angle Glaucoma (POAG)
Interventions
Device: iStent
First Posted Date
2012-01-25
Last Posted Date
2022-08-31
Lead Sponsor
Glaukos Corporation
Target Recruit Count
119
Registration Number
NCT01517477
Locations
🇦🇲

S.V. Malayan's Ophthalmology Centre, Yerevan, Armenia

Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery

Not Applicable
Completed
Conditions
Primary Open-angle Glaucoma
Interventions
Procedure: Cataract surgery
Device: iStent inject
First Posted Date
2011-10-28
Last Posted Date
2022-05-19
Lead Sponsor
Glaukos Corporation
Target Recruit Count
505
Registration Number
NCT01461291
Locations
🇺🇸

Eye Centers of Racine and Kenosha, Racine, Wisconsin, United States

Multicenter Investigation of the Glaukos® Suprachoroidal Stent Model G3 In Conjunction With Cataract Surgery

Not Applicable
Completed
Conditions
Primary Open-angle Glaucoma
Interventions
Procedure: Cataract surgery
Device: iStent supra
First Posted Date
2011-10-28
Last Posted Date
2022-05-19
Lead Sponsor
Glaukos Corporation
Target Recruit Count
505
Registration Number
NCT01461278
Locations
🇺🇸

Eye Centers of Racine and Kenosha, Racine, Wisconsin, United States

Open-Angle Glaucoma Subjects With One Prior Trabeculectomy Treated Concurrently With One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents

Not Applicable
Completed
Conditions
Open-Angle Glaucoma
Interventions
Device: iStent and iStent supra
First Posted Date
2011-10-20
Last Posted Date
2022-09-07
Lead Sponsor
Glaukos Corporation
Target Recruit Count
79
Registration Number
NCT01456390
Locations
🇦🇲

S.V. Malayan Ophthalmological Center, Yerevan, Armenia

Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Randomized to Treatment With One or Two Trabecular Micro-bypass Stents in Conjunction With Cataract Surgery

Not Applicable
Completed
Conditions
Open-angle Glaucoma
Interventions
Device: Two iStent
Device: One iStent
First Posted Date
2011-10-20
Last Posted Date
2022-08-31
Lead Sponsor
Glaukos Corporation
Target Recruit Count
79
Registration Number
NCT01455467
Locations
🇦🇲

S.V. Malayan Ophthalmological Center, Yerevan, Armenia

Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost

Phase 4
Completed
Conditions
Open-angle Glaucoma
Interventions
Device: iStent inject
First Posted Date
2011-09-30
Last Posted Date
2022-09-08
Lead Sponsor
Glaukos Corporation
Target Recruit Count
196
Registration Number
NCT01444040
Locations
🇦🇲

S.V. Malayan Ophthalmological Center, Yerevan, Armenia

Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment With Two Trabecular Micro-bypass Stents or Selective Laser Trabeculoplasty

Not Applicable
Completed
Conditions
Open-angle Glaucoma
Interventions
Device: iStent
Other: SLT
First Posted Date
2011-09-30
Last Posted Date
2022-08-31
Lead Sponsor
Glaukos Corporation
Target Recruit Count
80
Registration Number
NCT01444105
Locations
🇦🇲

S.V. Malayan Ophthalmological Center, Yerevan, Armenia

Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent)or Travoprost

Phase 4
Completed
Conditions
Open-angle Glaucoma
Interventions
Device: iStent
First Posted Date
2011-09-30
Last Posted Date
2017-12-18
Lead Sponsor
Glaukos Corporation
Target Recruit Count
101
Registration Number
NCT01443988
Locations
🇦🇲

S.V. Malayan Ophthalmological Center, Yerevan, Armenia

© Copyright 2025. All Rights Reserved by MedPath